- Home
- FOXO vs CPHI Comparison
FOXO vs CPHI Comparison
Compare FOXO & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOXO
- CPHI
- Stock Information
- Founded
- FOXO 2019
- CPHI N/A
- Country
- FOXO United States
- CPHI China
- Employees
- FOXO N/A
- CPHI N/A
- Industry
- FOXO Retail: Computer Software & Peripheral Equipment
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- FOXO Technology
- CPHI Health Care
- Exchange
- FOXO Nasdaq
- CPHI Nasdaq
- Market Cap
- FOXO 4.9M
- CPHI 4.0M
- IPO Year
- FOXO N/A
- CPHI N/A
- Fundamental
- Price
- FOXO $0.15
- CPHI $0.23
- Analyst Decision
- FOXO
- CPHI
- Analyst Count
- FOXO 0
- CPHI 0
- Target Price
- FOXO N/A
- CPHI N/A
- AVG Volume (30 Days)
- FOXO 5.9M
- CPHI 1.2M
- Earning Date
- FOXO 11-19-2024
- CPHI 03-31-2025
- Dividend Yield
- FOXO N/A
- CPHI N/A
- EPS Growth
- FOXO N/A
- CPHI N/A
- EPS
- FOXO N/A
- CPHI N/A
- Revenue
- FOXO $1,341,000.00
- CPHI $5,544,620.00
- Revenue This Year
- FOXO N/A
- CPHI N/A
- Revenue Next Year
- FOXO N/A
- CPHI N/A
- P/E Ratio
- FOXO N/A
- CPHI N/A
- Revenue Growth
- FOXO 196.03
- CPHI N/A
- 52 Week Low
- FOXO $0.13
- CPHI $0.13
- 52 Week High
- FOXO $1.30
- CPHI $0.44
- Technical
- Relative Strength Index (RSI)
- FOXO 35.01
- CPHI 53.63
- Support Level
- FOXO $0.14
- CPHI $0.21
- Resistance Level
- FOXO $0.17
- CPHI $0.25
- Average True Range (ATR)
- FOXO 0.02
- CPHI 0.03
- MACD
- FOXO 0.00
- CPHI 0.00
- Stochastic Oscillator
- FOXO 3.69
- CPHI 55.22
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.